Patients experiencing shortness of breath while taking tirzepatide should seek immediate medical attention if they develop any of the following warning signs: Seek emergency care immediately (call 911) for: Sudden onset of severe shortness of breath or difficulty breathing Chest pain, pressure, or tightness accompanying breathing difficulties Rapid heart rate, palpitations, or irregular heartbeat Swelling of the face, lips, tongue, or throat (suggesting anaphylaxis) Wheezing, stridor, or audible breathing difficulty Confusion, lightheadedness, or loss of consciousness Blue discoloration of lips or fingertips (cyanosis) These symptoms may indicate serious conditions requiring urgent evaluation, including acute coronary syndrome, pulmonary embolism, severe allergic reaction, or acute heart failure
They have several beneficial effects, including: Enhancing insulin secretion: They stimulate the pancreas to release insulin in response to meals, helping to control blood sugar levels
While GLP-1 medications have shown impressive results in reducing OSA severity, researchers and clinicians are clear that they are not a replacement for CPAP in those with significant disease
Now, increasingly, we're exploring combined approaches, where surgery provides durable, baseline weight loss and GLP-1 medications can be used strategically, either pre-surgery to improve surgical safety or even post-surgery to support long-term outcomes
Metabolism 49 , 709717 (2000)